FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to oncology, and can be used to determine duration of recurrence-free interval in serous ovarian cancer. For this purpose, during full volume operation in ovarian cancer patients HE4 level is determined in tumor tissue homogenate, and if its value is from 4,768 pM/g to 5,674 pM/g of raw tissue, recurrence-free interval duration is predicted for 6 months or more, and if its value is from 7,995 pM/g to 9,339 pM/g of raw tissue, duration of recurrence-free interval is predicted for less than 6 months.
EFFECT: method enables assessing biological activity of primary ovarian tumor, individual prognosis of disease and further approach of patients with multiple playback in healthcare facilities of oncological profile, possessing biochemical laboratories.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING RECURRENCE OF SEROUS OVARIAN CARCINOMA | 2020 |
|
RU2749361C1 |
| METHOD FOR PREDICTION OF PROBABILITY OF POSSIBLE EXECUTION OF OPTIMUM CYTOREDUCTIVE OPERATION IN PATIENTS WITH DISSEMINATED FORMS OF OVARIAN CANCER | 2017 |
|
RU2637399C1 |
| METHOD FOR PREDICTING DURATION OF DISEASE-FREE INTERVAL AFTER COMPLETION OF PRIMARY TREATMENT OF PATIENTS WITH OVARY CANCER | 2018 |
|
RU2676702C2 |
| METHOD FOR DETERMINING THE EFFECTIVENESS OF CHEMOTHERAPY WITH PLATINUM PREPARATIONS IN III-IV STAGE OVARIAN CANCER | 2020 |
|
RU2738167C1 |
| METHOD FOR PREDICTION OF RECURRENT OVARIAN CARCINOMA | 2013 |
|
RU2530556C1 |
| METHOD FOR PREDICTING THE RELAPSE OF SEROUS OVARIAN CANCER | 2005 |
|
RU2290078C1 |
| METHOD FOR PREDICTION OF OVARIAN CANCER PERITONEAL PROPAGATION | 2019 |
|
RU2722654C1 |
| METHOD FOR PREDICTION OF CYTOREDUCTIVE SURGERY VOLUME IN PATIENTS WITH ADVANCED OVARIAN CANCER AFTER COMPLETION OF THIRD COURSE OF NEOADJUVANT CHEMOTHERAPY | 2017 |
|
RU2671409C2 |
| METHOD FOR PREDICTION OF RISK OF TUMOUR PROGRESSION IN PATIENTS WITH OVARIAN CANCER | 2023 |
|
RU2816339C1 |
| METHOD FOR PREDICTING EARLY RECURRENCE OF CLEAR CELL CARCINOMA OF THE UTERINE BODY | 2022 |
|
RU2784775C1 |
